Cargando…

Safety and Effectiveness of Cell Therapy in Neurodegenerative Diseases: Take-Home Messages From a Pilot Feasibility Phase I Study of Progressive Supranuclear Palsy

Mesenchymal stromal cells (MSCs) are multipotent cells with anti-inflammatory properties. Here we tested the safety of MSCs in patients with progressive supranuclear palsy (PSP; ClinicalTrials.gov: NCT01824121; Eudract No. 2011-004051-39). Seven patients were treated. To improve the safety, protocol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Giordano, Rosaria, Canesi, Margherita, Isalberti, Maurizio, Marfia, Giovanni, Campanella, Rolando, Vincenti, Daniele, Cereda, Viviana, Ranghetti, Alessandra, Palmisano, Chiara, Isaias, Ioannis Ugo, Benti, Riccardo, Marotta, Giorgio, Lazzari, Lorenza, Montemurro, Tiziana, Viganò, Mariele, Budelli, Silvia, Montelatici, Elisa, Lavazza, Cristiana, Rivera-Ordaz, Araceli, Pezzoli, Gianni
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8546103/ https://www.ncbi.nlm.nih.gov/pubmed/34712113 http://dx.doi.org/10.3389/fnins.2021.723227

Ejemplares similares

Finding a new therapeutic approach for no-option Parkinsonisms: mesenchymal stromal cells for progressive supranuclear palsy
por: Canesi, Margherita, et al.
Publicado: (2016)

Autologous mesenchymal stem cell therapy for progressive supranuclear palsy: translation into a phase I controlled, randomized clinical study
por: Giordano, Rosaria, et al.
Publicado: (2014)

How we make cell therapy in Italy
por: Montemurro, Tiziana, et al.
Publicado: (2015)

Microtubule defects in mesenchymal stromal cells distinguish patients with Progressive Supranuclear Palsy
por: Calogero, Alessandra Maria, et al.
Publicado: (2018)

Tips and Tricks for Validation of Quality Control Analytical Methods in Good Manufacturing Practice Mesenchymal Stromal Cell Production
por: Viganò, Mariele, et al.
Publicado: (2018)

Process development and validation of expanded regulatory T cells for prospective applications: an example of manufacturing a personalized advanced therapy medicinal product
por: Lavazza, Cristiana, et al.
Publicado: (2022)

Gait initiation in progressive supranuclear palsy: brain metabolic correlates
por: Palmisano, Chiara, et al.
Publicado: (2020)

Divergent Thinking in Parkinsonism: A Case–Control Study
por: Canesi, Margherita, et al.
Publicado: (2017)

Validation of an automated cell counting method for cGMP manufacturing of human induced pluripotent stem cells
por: Manzini, Paolo, et al.
Publicado: (2022)

Hypomania, Depression, Euthymia: New Evidence in Parkinson's Disease
por: Canesi, Margherita, et al.
Publicado: (2020)

Rehabilitation in progressive supranuclear palsy: Effectiveness of two multidisciplinary treatments
por: Clerici, Ilaria, et al.
Publicado: (2017)

What is beyond a qRT-PCR study on mesenchymal stem cell differentiation properties: how to choose the most reliable housekeeping genes
por: Ragni, Enrico, et al.
Publicado: (2013)

First clinical application of cord blood mesenchymal stromal cells in children with multi-drug resistant nephrotic syndrome
por: Morello, William, et al.
Publicado: (2022)

Mitochondrial dysfunction in Parkinsonian mesenchymal stem cells impairs differentiation
por: Angelova, Plamena R., et al.
Publicado: (2017)

A role for locus coeruleus in Parkinson tremor
por: Isaias, Ioannis U., et al.
Publicado: (2012)

Changes in the proteomic profile of adipose tissue-derived mesenchymal stem cells during passages
por: Capra, Emanuele, et al.
Publicado: (2012)

Differentiation and migration properties of human foetal umbilical cord perivascular cells: potential for lung repair
por: Montemurro, Tiziana, et al.
Publicado: (2011)

Critical Analysis of cGMP Large-Scale Expansion Process in Bioreactors of Human Induced Pluripotent Stem Cells in the Framework of Quality by Design
por: Rivera-Ordaz, Araceli, et al.
Publicado: (2021)

Brain metabolic alterations herald falls in patients with Parkinson’s disease
por: Isaias, Ioannis U., et al.
Publicado: (2020)

Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Erratum to: Efficacy of rasagiline and selegiline in Parkinson’s disease: a head-to-head 3-year retrospective case–control study
por: Cereda, Emanuele, et al.
Publicado: (2017)

Gait Initiation Impairment in Patients with Parkinson’s Disease and Freezing of Gait
por: Palmisano, Chiara, et al.
Publicado: (2022)

The Influence of Dopaminergic Striatal Innervation on Upper Limb Locomotor Synergies
por: Isaias, Ioannis U., et al.
Publicado: (2012)

Sphingosine-1-Phosphate in the Tumor Microenvironment: A Signaling Hub Regulating Cancer Hallmarks
por: Riboni, Laura, et al.
Publicado: (2020)

Impaired reach-to-grasp kinematics in parkinsonian patients relates to dopamine-dependent, subthalamic beta bursts
por: Vissani, Matteo, et al.
Publicado: (2021)

Gait Initiation in Parkinson’s Disease: Impact of Dopamine Depletion and Initial Stance Condition
por: Palmisano, Chiara, et al.
Publicado: (2020)

Regulatory T cells from patients with end-stage organ disease can be isolated, expanded and cryopreserved according good manufacturing practice improving their function
por: Ulbar, Francesca, et al.
Publicado: (2019)

Predictors of COVID-19 outcome in Parkinson's disease
por: Fasano, Alfonso, et al.
Publicado: (2020)

Zolpidem in Progressive Supranuclear Palsy
por: Dash, Sandip K.
Publicado: (2013)

Genetics of Progressive Supranuclear Palsy
por: Im, Sun Young, et al.
Publicado: (2015)

Falls in Progressive Supranuclear Palsy
por: Brown, Fraser S., et al.
Publicado: (2019)

Enhanced catecholamine transporter binding in the locus coeruleus of patients with early Parkinson disease
por: Isaias, Ioannis U, et al.
Publicado: (2011)

Neuromelanin Imaging and Dopaminergic Loss in Parkinson's Disease
por: Isaias, Ioannis U., et al.
Publicado: (2016)

‘Hummingbird’ sign in progressive supranuclear palsy
por: Shukla, Rakesh, et al.
Publicado: (2009)

Clinical Approach to Progressive Supranuclear Palsy
por: Ling, Helen
Publicado: (2016)

Managing cognition in progressive supranuclear palsy
por: Rittman, Timothy, et al.
Publicado: (2016)

Hummingbird sign in progressive supranuclear palsy
por: Verma, Rajesh, et al.
Publicado: (2012)

Imaging in the diagnosis of progressive supranuclear palsy
por: Smith, Matthew D., et al.
Publicado: (2018)

Multireceptor fingerprints in progressive supranuclear palsy
por: Chiu, Wang Zheng, et al.
Publicado: (2017)

Frontrunner in Translation: Progressive Supranuclear Palsy
por: Shoeibi, Ali, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4h89bmtvgvuk27cs3il8hhsbcr